Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23182627 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy
Condition: Unresectable Hepatocellular Carcinoma
Interventions: Drug: ARQ 197;   Drug: Placebo

Indicates status has not been verified in more than two years